Alexander Georg Marneros, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ectodermal Dysplasia | 4 | 2023 | 106 | 2.180 |
Why?
|
| Choroidal Neovascularization | 6 | 2020 | 343 | 2.090 |
Why?
|
| Co-Repressor Proteins | 5 | 2023 | 194 | 1.870 |
Why?
|
| Retinal Pigment Epithelium | 6 | 2020 | 302 | 1.700 |
Why?
|
| Vascular Endothelial Growth Factor A | 11 | 2020 | 3510 | 1.590 |
Why?
|
| Nephrons | 3 | 2022 | 220 | 1.540 |
Why?
|
| Keloid | 4 | 2018 | 50 | 1.320 |
Why?
|
| Inflammasomes | 3 | 2020 | 496 | 1.250 |
Why?
|
| Macular Degeneration | 6 | 2020 | 981 | 1.180 |
Why?
|
| beta Catenin | 2 | 2022 | 1060 | 1.080 |
Why?
|
| Collagen Type XVIII | 6 | 2007 | 56 | 0.920 |
Why?
|
| Endostatins | 6 | 2007 | 174 | 0.880 |
Why?
|
| Transcription Factor AP-2 | 1 | 2022 | 82 | 0.830 |
Why?
|
| Neural Crest | 1 | 2023 | 275 | 0.790 |
Why?
|
| Macrophage Activation | 2 | 2021 | 559 | 0.740 |
Why?
|
| Choroid | 4 | 2019 | 322 | 0.730 |
Why?
|
| Morphogenesis | 2 | 2014 | 751 | 0.720 |
Why?
|
| Epidermal Growth Factor | 1 | 2022 | 709 | 0.680 |
Why?
|
| Complement Activation | 1 | 2020 | 453 | 0.660 |
Why?
|
| Macrophages | 3 | 2021 | 5651 | 0.620 |
Why?
|
| Complement System Proteins | 1 | 2020 | 796 | 0.600 |
Why?
|
| Magnesium | 1 | 2021 | 813 | 0.600 |
Why?
|
| Pigment Epithelium of Eye | 4 | 2005 | 220 | 0.590 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 789 | 0.550 |
Why?
|
| Neovascularization, Physiologic | 3 | 2018 | 1351 | 0.530 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2016 | 188 | 0.520 |
Why?
|
| Cardiomegaly | 1 | 2018 | 621 | 0.500 |
Why?
|
| Vision, Ocular | 3 | 2014 | 457 | 0.490 |
Why?
|
| Aging | 6 | 2018 | 8655 | 0.480 |
Why?
|
| Epidermis | 2 | 2023 | 529 | 0.460 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2013 | 62 | 0.460 |
Why?
|
| Pericytes | 1 | 2016 | 293 | 0.460 |
Why?
|
| GTP Phosphohydrolases | 2 | 2014 | 508 | 0.450 |
Why?
|
| Fibrosis | 1 | 2020 | 2030 | 0.450 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2013 | 24 | 0.450 |
Why?
|
| Kidney Tubules, Distal | 2 | 2022 | 46 | 0.430 |
Why?
|
| Hypospadias | 1 | 2013 | 92 | 0.420 |
Why?
|
| Doxycycline | 1 | 2014 | 326 | 0.420 |
Why?
|
| Scalp | 4 | 2023 | 378 | 0.410 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2014 | 2037 | 0.410 |
Why?
|
| Integrases | 1 | 2014 | 533 | 0.400 |
Why?
|
| Muscle Hypotonia | 1 | 2013 | 165 | 0.400 |
Why?
|
| Proteome | 1 | 2021 | 1794 | 0.400 |
Why?
|
| Carrier Proteins | 2 | 2016 | 5021 | 0.390 |
Why?
|
| Exanthema | 2 | 2021 | 501 | 0.380 |
Why?
|
| Retina | 5 | 2016 | 2612 | 0.370 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9731 | 0.370 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 491 | 0.370 |
Why?
|
| Eye Diseases | 1 | 2016 | 668 | 0.360 |
Why?
|
| Proteomics | 2 | 2021 | 3639 | 0.360 |
Why?
|
| Aminopterin | 1 | 2009 | 15 | 0.350 |
Why?
|
| Gene Dosage | 1 | 2014 | 1252 | 0.350 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1968 | 0.340 |
Why?
|
| Skin | 3 | 2014 | 4372 | 0.340 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1861 | 0.340 |
Why?
|
| Folic Acid Antagonists | 1 | 2009 | 84 | 0.330 |
Why?
|
| Mice | 19 | 2022 | 81154 | 0.320 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2009 | 166 | 0.320 |
Why?
|
| Animals | 24 | 2022 | 168660 | 0.310 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 784 | 0.310 |
Why?
|
| Calcium | 1 | 2021 | 5755 | 0.300 |
Why?
|
| Vascular Neoplasms | 1 | 2009 | 175 | 0.300 |
Why?
|
| Cicatrix | 1 | 2013 | 763 | 0.300 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2012 | 545 | 0.290 |
Why?
|
| Mutation, Missense | 2 | 2013 | 2566 | 0.290 |
Why?
|
| Mammals | 2 | 2022 | 1143 | 0.280 |
Why?
|
| Iris | 2 | 2005 | 239 | 0.270 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1416 | 0.260 |
Why?
|
| Collagen | 3 | 2003 | 2681 | 0.260 |
Why?
|
| Repressor Proteins | 2 | 2014 | 3024 | 0.260 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2009 | 640 | 0.260 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5532 | 0.260 |
Why?
|
| Myocardium | 1 | 2018 | 4775 | 0.250 |
Why?
|
| Interleukin-4 | 2 | 2021 | 1147 | 0.250 |
Why?
|
| Signal Transduction | 6 | 2021 | 23398 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 21824 | 0.240 |
Why?
|
| Eye Abnormalities | 2 | 2003 | 246 | 0.230 |
Why?
|
| Rhodopsin | 3 | 2014 | 203 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 2 | 2016 | 2638 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2004 | 322 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 12066 | 0.220 |
Why?
|
| Iris Diseases | 1 | 2003 | 40 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2004 | 326 | 0.220 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11478 | 0.220 |
Why?
|
| Electroretinography | 3 | 2014 | 509 | 0.220 |
Why?
|
| Mice, Knockout | 7 | 2020 | 14563 | 0.210 |
Why?
|
| Exfoliation Syndrome | 1 | 2003 | 110 | 0.210 |
Why?
|
| Wound Healing | 1 | 2013 | 2776 | 0.200 |
Why?
|
| Bruch Membrane | 3 | 2007 | 64 | 0.200 |
Why?
|
| Skin Neoplasms | 2 | 2012 | 5691 | 0.200 |
Why?
|
| Peptide Fragments | 3 | 2003 | 5096 | 0.200 |
Why?
|
| Skin Diseases, Genetic | 1 | 2001 | 41 | 0.200 |
Why?
|
| Contig Mapping | 1 | 2001 | 54 | 0.200 |
Why?
|
| Caspases, Initiator | 1 | 2020 | 32 | 0.190 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18027 | 0.190 |
Why?
|
| Collagen Type IV | 1 | 2001 | 140 | 0.190 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2001 | 50 | 0.190 |
Why?
|
| Dermatologic Agents | 1 | 2004 | 278 | 0.190 |
Why?
|
| Potassium Channels | 1 | 2023 | 563 | 0.190 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2022 | 416 | 0.180 |
Why?
|
| Caspase 1 | 1 | 2020 | 224 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 367 | 0.170 |
Why?
|
| Kidney Glomerulus | 1 | 2022 | 697 | 0.170 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 973 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 646 | 0.160 |
Why?
|
| Organogenesis | 1 | 2020 | 222 | 0.160 |
Why?
|
| Tretinoin | 1 | 2021 | 517 | 0.160 |
Why?
|
| Geographic Atrophy | 1 | 2019 | 66 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2001 | 473 | 0.160 |
Why?
|
| PPAR gamma | 1 | 2021 | 492 | 0.160 |
Why?
|
| Pedigree | 3 | 2013 | 4643 | 0.160 |
Why?
|
| Introns | 1 | 2001 | 991 | 0.160 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 144 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7172 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 3847 | 0.130 |
Why?
|
| Kidney | 2 | 2022 | 7185 | 0.130 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 1862 | 0.130 |
Why?
|
| Face | 1 | 2021 | 993 | 0.130 |
Why?
|
| Basement Membrane | 3 | 2005 | 357 | 0.120 |
Why?
|
| Humans | 26 | 2023 | 743811 | 0.120 |
Why?
|
| Exons | 1 | 2001 | 2438 | 0.120 |
Why?
|
| Lens, Crystalline | 1 | 2016 | 388 | 0.120 |
Why?
|
| Genetic Linkage | 2 | 2013 | 2419 | 0.120 |
Why?
|
| Retinoids | 1 | 2014 | 101 | 0.120 |
Why?
|
| Ciliary Body | 2 | 2005 | 173 | 0.110 |
Why?
|
| Male | 17 | 2022 | 349776 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2013 | 10477 | 0.110 |
Why?
|
| Fundus Oculi | 1 | 2014 | 473 | 0.110 |
Why?
|
| Apoptosis | 1 | 2009 | 9718 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2110 | 0.110 |
Why?
|
| Phenotype | 3 | 2021 | 16361 | 0.110 |
Why?
|
| Ear, External | 1 | 2013 | 161 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2014 | 389 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2013 | 222 | 0.100 |
Why?
|
| Melanoma | 2 | 2009 | 5508 | 0.100 |
Why?
|
| Nipples | 1 | 2013 | 219 | 0.100 |
Why?
|
| Penetrance | 2 | 2004 | 381 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2014 | 601 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2646 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2021 | 8436 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2899 | 0.090 |
Why?
|
| Genes, Dominant | 2 | 2004 | 880 | 0.090 |
Why?
|
| Fluorescein Angiography | 2 | 2005 | 940 | 0.090 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 436 | 0.090 |
Why?
|
| Ribosomes | 1 | 2013 | 500 | 0.090 |
Why?
|
| Homeostasis | 1 | 2021 | 3337 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 505 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2012 | 1472 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 2839 | 0.080 |
Why?
|
| Interleukins | 1 | 2013 | 791 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 6620 | 0.080 |
Why?
|
| Facial Dermatoses | 1 | 2008 | 87 | 0.080 |
Why?
|
| Etoposide | 1 | 2009 | 641 | 0.080 |
Why?
|
| Pichia | 1 | 2007 | 51 | 0.070 |
Why?
|
| Zidovudine | 1 | 2009 | 620 | 0.070 |
Why?
|
| Fluoresceins | 1 | 2007 | 235 | 0.070 |
Why?
|
| Syndrome | 2 | 2005 | 3249 | 0.070 |
Why?
|
| Vincristine | 1 | 2009 | 1039 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2200 | 0.070 |
Why?
|
| Female | 12 | 2022 | 380020 | 0.070 |
Why?
|
| Drug Eruptions | 1 | 2009 | 297 | 0.070 |
Why?
|
| Genome, Human | 2 | 2013 | 4418 | 0.070 |
Why?
|
| Melanoma, Experimental | 1 | 2009 | 560 | 0.070 |
Why?
|
| Microphthalmos | 1 | 2005 | 54 | 0.070 |
Why?
|
| Actins | 1 | 2013 | 2121 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 1222 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18107 | 0.060 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2005 | 118 | 0.060 |
Why?
|
| Chemokines | 1 | 2009 | 968 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2009 | 895 | 0.060 |
Why?
|
| Mutation | 4 | 2014 | 29777 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 4737 | 0.060 |
Why?
|
| Histocytochemistry | 1 | 2005 | 719 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2009 | 808 | 0.060 |
Why?
|
| Prednisone | 1 | 2009 | 1574 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2506 | 0.060 |
Why?
|
| Heparitin Sulfate | 1 | 2005 | 225 | 0.060 |
Why?
|
| Encephalocele | 1 | 2005 | 136 | 0.060 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2005 | 204 | 0.060 |
Why?
|
| Eye | 2 | 2005 | 727 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2009 | 496 | 0.060 |
Why?
|
| Cell Survival | 1 | 2014 | 5881 | 0.060 |
Why?
|
| Uveal Diseases | 1 | 2003 | 45 | 0.060 |
Why?
|
| Laminin | 1 | 2005 | 419 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2007 | 798 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 319 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 2241 | 0.060 |
Why?
|
| Ophthalmoscopy | 1 | 2003 | 176 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3082 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 429 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2009 | 2234 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 528 | 0.050 |
Why?
|
| Capillaries | 1 | 2005 | 773 | 0.050 |
Why?
|
| Retinal Vessels | 2 | 2005 | 772 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 627 | 0.050 |
Why?
|
| Chickens | 1 | 2003 | 864 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 20827 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2001 | 26 | 0.050 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 94 | 0.050 |
Why?
|
| Melanins | 1 | 2003 | 289 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2924 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13809 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3690 | 0.050 |
Why?
|
| Retinal Degeneration | 1 | 2005 | 415 | 0.050 |
Why?
|
| Blindness | 1 | 2005 | 612 | 0.050 |
Why?
|
| Vitamin A | 1 | 2003 | 615 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 683 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 12954 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2021 | 143 | 0.040 |
Why?
|
| Japan | 1 | 2004 | 1360 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 40038 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2001 | 209 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2001 | 450 | 0.040 |
Why?
|
| Cell Line | 1 | 2014 | 15993 | 0.040 |
Why?
|
| Family Health | 1 | 2004 | 1280 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10629 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2009 | 4162 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 4848 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 11524 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2005 | 1055 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19232 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2217 | 0.040 |
Why?
|
| Haplotypes | 1 | 2004 | 2779 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3476 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 733 | 0.040 |
Why?
|
| Biopsy | 1 | 2009 | 6750 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8637 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 1596 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9440 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3706 | 0.040 |
Why?
|
| Age Factors | 1 | 2013 | 18355 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3482 | 0.030 |
Why?
|
| Stem Cells | 1 | 2009 | 3566 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2003 | 5179 | 0.030 |
Why?
|
| Head | 1 | 2021 | 878 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 1743 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11360 | 0.030 |
Why?
|
| Gene Expression | 2 | 2005 | 7793 | 0.030 |
Why?
|
| Age of Onset | 1 | 2001 | 3268 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2001 | 2634 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 15518 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1616 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 7908 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 13691 | 0.030 |
Why?
|
| Disease Progression | 1 | 2009 | 13273 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 4183 | 0.030 |
Why?
|
| Rats | 1 | 2007 | 24250 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7880 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7270 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9582 | 0.020 |
Why?
|
| Incidence | 1 | 2001 | 20948 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 17439 | 0.010 |
Why?
|
| Adult | 2 | 2009 | 213889 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 771 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 2002 | 345 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 693 | 0.010 |
Why?
|
| Lymphokines | 1 | 2002 | 948 | 0.010 |
Why?
|
| Middle Aged | 2 | 2009 | 213241 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20121 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2327 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 163178 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57744 | 0.010 |
Why?
|
| United States | 1 | 2001 | 69859 | 0.010 |
Why?
|
| Child | 1 | 2001 | 77637 | 0.010 |
Why?
|
| Adolescent | 1 | 2001 | 85729 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 4033 | 0.010 |
Why?
|